Additionally, miR-31-5p alleviates sepsis-induced cardiomyopathy by inhibiting the deubiquitination of SLC7A11 via targeting BAP1, thereby also counteracting ferroptosis (215). Here, BAP1 is linked to cardiomyopathy.